---
title: "Guangxi LiuYao Group Co., Ltd (603368.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603368.SH.md"
symbol: "603368.SH"
name: "Guangxi LiuYao Group Co., Ltd"
industry: "Health Care Distributors"
datetime: "2026-05-20T22:46:52.701Z"
locales:
  - [en](https://longbridge.com/en/quote/603368.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603368.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603368.SH.md)
---

# Guangxi LiuYao Group Co., Ltd (603368.SH)

## Company Overview

Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It offers various types of medicines, medical devices, consumables, and test reagents through online pharmacies and terminal physical pharmacies. The company was founded in 1981 and is based in Liuzhou, China.

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Exchange | CN Market |
| Website | [www.lzyy.cn](https://www.lzyy.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: C (0.46)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 23 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.26% |  |
| Net Profit YoY | -21.05% |  |
| P/B Ratio | 0.83 |  |
| Dividend Ratio | 4.57% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 6537790719.56 |  |
| Revenue | 21023894848.54 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 8.26% | B |
| Profit Margin | 3.13% | C |
| Gross Margin | 11.56% | D |
| Revenue YoY | 1.26% | C |
| Net Profit YoY | -21.05% | D |
| Total Assets YoY | -0.85% | D |
| Net Assets YoY | 1.19% | C |
| Cash Flow Margin | 165.38% | B |
| OCF YoY | 1.26% | C |
| Turnover | 1.00 | A |
| Gearing Ratio | 60.06% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Guangxi LiuYao Group Co., Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "1.26%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-21.05%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.83",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "4.57%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "6537790719.56",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "21023894848.54",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "8.26%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "3.13%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "11.56%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "1.26%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-21.05%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.85%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "1.19%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "165.38%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "1.26%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "1.00",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "60.06%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 9.83 | 2/23 | 9.30 | 8.99 | 8.46 |
| PB | 0.82 | 4/23 | 0.98 | 0.93 | 0.88 |
| PS (TTM) | 0.31 | 10/23 | 0.35 | 0.34 | 0.32 |
| Dividend Yield | 4.62% | 1/23 | 4.42% | 4.18% | 4.02% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | HUADONG MEDICINE (000963.SZ) | B | C | A | B | C | B |
| 02 | SINOPHARM(CNCM LTD) (600511.SH) | C | C | A | C | C | B |
| 03 | TIBET PHARMA (600211.SH) | A | C | C | B | C | B |
| 04 | Shanghai Pharma (601607.SH) | C | C | A | D | C | C |
| 05 | GYBYS (600332.SH) | C | C | A | C | C | C |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-01T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 16.26 |
| Highest Target | 21.70 |
| Lowest Target | 21.70 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/603368.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/603368.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/603368.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/603368.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**